Expert Pharmacy Insights
Evidence-based health articles, medication guides, and wellness tips from certified pharmacists
Bimatoprost for Eyebrows: What the Trials Show About Off Label Use
Bimatoprost is FDA approved for eyelashes, not eyebrows, so brow use is off label and rarely discussed properly. A Phase 3 trial and three smaller randomised studies say it works. This guide covers the evidence, a realistic timeline, how brow application differs from lashes, and the risks worth taking seriously.
Is Careprost Legal in the USA? FDA Status, Prescription Rules and Counterfeit Risk
Careprost is not FDA approved and bimatoprost is prescription only in the US for every use, including lash growth. An accurate read of the law, the FDA label warnings, and how to tell a real supplier from a dangerous one.
Lumigan vs Careprost: Same Bimatoprost, Different Strengths and What That Means
Lumigan and Careprost share an active ingredient, bimatoprost, but US Lumigan is now 0.01% while Careprost is 0.03%. This guide covers what the strength difference means for eye pressure and redness, how bimatoprost ranks among glaucoma drops, 2026 US pharmacy costs, Medicare, eyelash use and why switching needs an eye doctor.
Careprost vs Latisse: Same Bimatoprost 0.03%, What Differs and What It Costs
Careprost and Latisse share the same drug and strength, bimatoprost 0.03%. This guide compares approval, applicators, the Latisse trial results, 2026 US pharmacy costs including cheaper FDA-approved generics, whether insurance or Medicare pays, side effects and who should not use either.
Showing 1-4 of 4 articles